These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2985256)

  • 1. Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung.
    Souhami RL; Bradbury I; Geddes DM; Spiro SG; Harper PG; Tobias JS
    Cancer Res; 1985 Jun; 45(6):2878-82. PubMed ID: 2985256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in small cell lung cancer: multivariate model based on 778 patients treated with chemotherapy with or without irradiation.
    Osterlind K; Andersen PK
    Cancer Res; 1986 Aug; 46(8):4189-94. PubMed ID: 3015384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raised serum urea predicts for early death in small cell lung cancer.
    Winter MC; Potter VA; Woll PJ
    Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):745-50. PubMed ID: 18845424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small cell lung cancer.
    Cohen MH; Makuch R; Johnston-Early A; Ihde DC; Bunn PA; Fossieck BE; Minna JD
    Cancer Treat Rep; 1981; 65(3-4):187-95. PubMed ID: 6263468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in elderly patients with unresectable non-small cell lung cancer.
    Kimura T; Kudoh S; Hirata K; Takifuji N; Negoro S; Yoshikawa J
    Anticancer Res; 2001; 21(2B):1379-83. PubMed ID: 11396218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pre-therapeutic prognostic factors of survival in small cell bronchial cancer. Retrospective study in a series of 112 patients].
    Quoix E; Hedelin G; Seibert R; Popin E; Dietemann A; Roeslin N; Pauli G
    Rev Mal Respir; 1993; 10(1):29-34. PubMed ID: 8383869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
    Milman N; Pedersen LM
    Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of 21-day oral etoposide given in combination with i.v. cisplatin in patients with extensive-stage small cell lung cancer: a cancer and leukemia group B study (CALGB 9062).
    Miller AA; Rosner GL; Ratain MJ; Hollis DR; Green MR; Schilsky RL
    Clin Cancer Res; 1997 May; 3(5):719-25. PubMed ID: 9815741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and prognostic factors in lung cancer patients treated in phase I trials: Japanese experience.
    Yamamoto N; Tamura T; Fukuoka M; Saijo N
    Int J Oncol; 1999 Oct; 15(4):737-41. PubMed ID: 10493956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
    Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L
    Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer.
    Johnson PW; Muers MF; Peake MD; Poulter KM; Gurney EM; Napp VV; Hepburn PM; Brown JM
    Br J Cancer; 2001 Jan; 84(1):19-24. PubMed ID: 11139307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bibliographic analysis of the use of laboratory blood parameters for the prognosis of primary lung cancer].
    Watine J; Rouzaud P; Charet JC
    Ann Biol Clin (Paris); 1999; 57(1):57-68. PubMed ID: 9920968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor size, response rate, and prognosis in small cell carcinoma of the bronchus treated by combination chemotherapy.
    Harper PG; Souhami RL; Spiro SG; Geddes DM; Guimaraes M; Fearon F; Smyth JF
    Cancer Treat Rep; 1982 Mar; 66(3):463-70. PubMed ID: 6277486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of DNA topoisomerase IIalpha and topoisomerase IIbeta genes predicts survival and response to chemotherapy in patients with small cell lung cancer.
    Dingemans AM; Witlox MA; Stallaert RA; van der Valk P; Postmus PE; Giaccone G
    Clin Cancer Res; 1999 Aug; 5(8):2048-58. PubMed ID: 10473085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression.
    Lassen UN; Osterlind K; Hirsch FR; Bergman B; Dombernowsky P; Hansen HH
    Br J Cancer; 1999 Feb; 79(3-4):515-9. PubMed ID: 10027322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between the tumor marker Pro-GRP and prognosis in patients with small-cell lung cancer].
    Tsuchiyama T; Kawahara M; Naka N; Yamamoto S; Nakao M; Kamimori T; Okada T; Atagi S; Ogawara M; Furuse K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jun; 35(6):616-21. PubMed ID: 9294294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.
    Ruotsalainen T; Joensuu H; Mattson K; Salven P
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1492-5. PubMed ID: 12433733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR; Ding K; Seymour L; Shepherd FA; Leighl NB; Winton TL; Whitehead M; Spaans JN; Graham BC; Goss GD;
    J Clin Oncol; 2008 Jan; 26(1):54-9. PubMed ID: 18165640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.